Global Anti-Emetic Drug Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 105
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Oral

- Injection

- Others

Segment by Application

- Hospital

- Clinic

- Home Care

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merck

- Novartis

- Glenmark Pharmaceuticals

- F. Hoffmann-La Roche

- Heron Therapeutics

- Kyowa Kirin

- Aurobindo Pharma

- Mylan

- Hikma

- Akorn

- Dr. Reddy's Laboratories

- Cipla

- Fresenius Kabi

- Wockhardt

- Sun Pharmaceutical Industries

- Teva Pharmaceutical

- Pfizer

Global Anti-Emetic Drug Market Research Report 2022

Table of Contents
1 Anti-Emetic Drug Market Overview
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Anti-Emetic Drug Segment by Application
1.3.1 Global Anti-Emetic Drug Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2017-2028
1.4.2 Global Anti-Emetic Drug Sales 2017-2028
1.4.3 Anti-Emetic Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-Emetic Drug Market Competition by Manufacturers
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Emetic Drug Market Competitive Situation and Trends
2.5.1 Anti-Emetic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
2.5.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Emetic Drug Retrospective Market Scenario by Region
3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
3.3.1 North America Anti-Emetic Drug Sales by Country
3.3.2 North America Anti-Emetic Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Emetic Drug Sales by Country
3.4.2 Europe Anti-Emetic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.2 Asia Pacific Anti-Emetic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Emetic Drug Sales by Country
3.6.2 Latin America Anti-Emetic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.2 Middle East and Africa Anti-Emetic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Emetic Drug Historic Market Analysis by Type
4.1 Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)
4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2017-2022)
4.3 Global Anti-Emetic Drug Price by Type (2017-2022)
5 Global Anti-Emetic Drug Historic Market Analysis by Application
5.1 Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)
5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2017-2022)
5.3 Global Anti-Emetic Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Anti-Emetic Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novartis Anti-Emetic Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Glenmark Pharmaceuticals Anti-Emetic Drug Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 F. Hoffmann-La Roche Anti-Emetic Drug Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description and Business Overview
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Heron Therapeutics Anti-Emetic Drug Product Portfolio
6.5.5 Heron Therapeutics Recent Developments/Updates
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description and Business Overview
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Kyowa Kirin Anti-Emetic Drug Product Portfolio
6.6.5 Kyowa Kirin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Aurobindo Pharma Anti-Emetic Drug Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Mylan Anti-Emetic Drug Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hikma Anti-Emetic Drug Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Akorn Anti-Emetic Drug Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Anti-Emetic Drug Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Dr. Reddy's Laboratories Anti-Emetic Drug Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Cipla Anti-Emetic Drug Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Fresenius Kabi Anti-Emetic Drug Product Portfolio
6.13.5 Fresenius Kabi Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Wockhardt Anti-Emetic Drug Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Sun Pharmaceutical Industries Anti-Emetic Drug Product Portfolio
6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Teva Pharmaceutical Anti-Emetic Drug Product Portfolio
6.16.5 Teva Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Pfizer Anti-Emetic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
7 Anti-Emetic Drug Manufacturing Cost Analysis
7.1 Anti-Emetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Emetic Drug
7.4 Anti-Emetic Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Emetic Drug Distributors List
8.3 Anti-Emetic Drug Customers
9 Anti-Emetic Drug Market Dynamics
9.1 Anti-Emetic Drug Industry Trends
9.2 Anti-Emetic Drug Market Drivers
9.3 Anti-Emetic Drug Market Challenges
9.4 Anti-Emetic Drug Market Restraints
10 Global Market Forecast
10.1 Anti-Emetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2023-2028)
10.2 Anti-Emetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2023-2028)
10.3 Anti-Emetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Anti-Emetic Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Anti-Emetic Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Anti-Emetic Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Anti-Emetic Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Anti-Emetic Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Anti-Emetic Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Anti-Emetic Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Anti-Emetic Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Emetic Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Emetic Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Emetic Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global Anti-Emetic Drug Sales Market Share by Region (2017-2022)
Table 17. Global Anti-Emetic Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Anti-Emetic Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 21. North America Anti-Emetic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Anti-Emetic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Anti-Emetic Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Anti-Emetic Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Anti-Emetic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Anti-Emetic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 41. Global Anti-Emetic Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Anti-Emetic Drug Revenue Share by Type (2017-2022)
Table 43. Global Anti-Emetic Drug Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Anti-Emetic Drug Sales (K Units) by Application (2017-2022)
Table 45. Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 46. Global Anti-Emetic Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Anti-Emetic Drug Revenue Share by Application (2017-2022)
Table 48. Global Anti-Emetic Drug Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Anti-Emetic Drug Product
Table 53. Merck Recent Developments/Updates
Table 54. Novartis Corporation Information
Table 55. Novartis Description and Business Overview
Table 56. Novartis Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Novartis Anti-Emetic Drug Product
Table 58. Novartis Recent Developments/Updates
Table 59. Glenmark Pharmaceuticals Corporation Information
Table 60. Glenmark Pharmaceuticals Description and Business Overview
Table 61. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Glenmark Pharmaceuticals Anti-Emetic Drug Product
Table 63. Glenmark Pharmaceuticals Recent Developments/Updates
Table 64. F. Hoffmann-La Roche Corporation Information
Table 65. F. Hoffmann-La Roche Description and Business Overview
Table 66. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. F. Hoffmann-La Roche Anti-Emetic Drug Product
Table 68. F. Hoffmann-La Roche Recent Developments/Updates
Table 69. Heron Therapeutics Corporation Information
Table 70. Heron Therapeutics Description and Business Overview
Table 71. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Heron Therapeutics Anti-Emetic Drug Product
Table 73. Heron Therapeutics Recent Developments/Updates
Table 74. Kyowa Kirin Corporation Information
Table 75. Kyowa Kirin Description and Business Overview
Table 76. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Kyowa Kirin Anti-Emetic Drug Product
Table 78. Kyowa Kirin Recent Developments/Updates
Table 79. Aurobindo Pharma Corporation Information
Table 80. Aurobindo Pharma Description and Business Overview
Table 81. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Aurobindo Pharma Anti-Emetic Drug Product
Table 83. Aurobindo Pharma Recent Developments/Updates
Table 84. Mylan Corporation Information
Table 85. Mylan Description and Business Overview
Table 86. Mylan Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Mylan Anti-Emetic Drug Product
Table 88. Mylan Recent Developments/Updates
Table 89. Hikma Corporation Information
Table 90. Hikma Description and Business Overview
Table 91. Hikma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hikma Anti-Emetic Drug Product
Table 93. Hikma Recent Developments/Updates
Table 94. Akorn Corporation Information
Table 95. Akorn Description and Business Overview
Table 96. Akorn Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Akorn Anti-Emetic Drug Product
Table 98. Akorn Recent Developments/Updates
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Description and Business Overview
Table 101. Dr. Reddy's Laboratories Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Dr. Reddy's Laboratories Anti-Emetic Drug Product
Table 103. Dr. Reddy's Laboratories Recent Developments/Updates
Table 104. Cipla Corporation Information
Table 105. Cipla Description and Business Overview
Table 106. Cipla Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Cipla Anti-Emetic Drug Product
Table 108. Cipla Recent Developments/Updates
Table 109. Fresenius Kabi Corporation Information
Table 110. Fresenius Kabi Description and Business Overview
Table 111. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Fresenius Kabi Anti-Emetic Drug Product
Table 113. Fresenius Kabi Recent Developments/Updates
Table 114. Wockhardt Corporation Information
Table 115. Wockhardt Description and Business Overview
Table 116. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Wockhardt Anti-Emetic Drug Product
Table 118. Wockhardt Recent Developments/Updates
Table 119. Sun Pharmaceutical Industries Corporation Information
Table 120. Sun Pharmaceutical Industries Description and Business Overview
Table 121. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Sun Pharmaceutical Industries Anti-Emetic Drug Product
Table 123. Sun Pharmaceutical Industries Recent Developments/Updates
Table 124. Teva Pharmaceutical Corporation Information
Table 125. Teva Pharmaceutical Description and Business Overview
Table 126. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Teva Pharmaceutical Anti-Emetic Drug Product
Table 128. Teva Pharmaceutical Recent Developments/Updates
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Business Overview
Table 131. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Pfizer Anti-Emetic Drug Product
Table 133. Pfizer Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Anti-Emetic Drug Distributors List
Table 137. Anti-Emetic Drug Customers List
Table 138. Anti-Emetic Drug Market Trends
Table 139. Anti-Emetic Drug Market Drivers
Table 140. Anti-Emetic Drug Market Challenges
Table 141. Anti-Emetic Drug Market Restraints
Table 142. Global Anti-Emetic Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 143. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Anti-Emetic Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Anti-Emetic Drug Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Anti-Emetic Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 147. Global Anti-Emetic Drug Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Anti-Emetic Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Anti-Emetic Drug Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Anti-Emetic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 151. Global Anti-Emetic Drug Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Anti-Emetic Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Emetic Drug
Figure 2. Global Anti-Emetic Drug Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Emetic Drug Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Home Care
Figure 10. Others
Figure 11. Global Anti-Emetic Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anti-Emetic Drug Market Size (2017-2028) & (US$ Million)
Figure 13. Global Anti-Emetic Drug Sales (2017-2028) & (K Units)
Figure 14. Anti-Emetic Drug Sales Share by Manufacturers in 2021
Figure 15. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Anti-Emetic Drug Players: Market Share by Revenue in 2021
Figure 17. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Anti-Emetic Drug Sales Market Share by Region (2017-2022)
Figure 19. Global Anti-Emetic Drug Sales Market Share by Region in 2021
Figure 20. Global Anti-Emetic Drug Revenue Market Share by Region (2017-2022)
Figure 21. Global Anti-Emetic Drug Revenue Market Share by Region in 2021
Figure 22. U.S. Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Anti-Emetic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Anti-Emetic Drug by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Anti-Emetic Drug
Figure 48. Manufacturing Process Analysis of Anti-Emetic Drug
Figure 49. Anti-Emetic Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Tenosynovitis Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Tenosynovitis Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tenosynovitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Nonsteroidal Anti-inflammatory Drugs (NSAIDs) - Antibiotics - Corticos......
  • Global Ephedrine Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 71
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Capsule - Injection Segment by Application - Bronchial Asthma - Other......
  • Global Woman Disease Pharmaceutical Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 95
    Woman Disease Pharmaceutical market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Woman Disease Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - OTC - Prescription Segment by Application......
  • Global Zinc Oxide Bandages Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Zinc Oxide 10% - Zinc Oxide 20% - Others Segment by Application - Orthopedic -......
  • Global Vinca Alkaloids Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 86
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oncovin - Velban - Navelbine Segment by Application - Lymphoma - Sarcoma......
  • Global Vitamin C Chewable Tablet Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 106
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Fruit Flavour - Other Segment by Application - Adult - Elderly - Children......
  • Global Central Nervous System (CNS) Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Central Nervous System (CNS) Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Prescription Drugs - OTC Segment b......
  • Global Liver Supplement Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 102
    Liver Supplement market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Liver Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Tablets - Capsules - Others Segment by Application - O......
  • Global Cancer Medication Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 90
    Cancer Medication market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Antimetabolite - Alkaloid Drugs - Hormone - Targeted Drug - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs